Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2017

Dec 21, 2017

65124_rns_2017-12-21_6dc510ad-8283-44de-8bae-d9780bb72a98.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Name of entity

Imugene Limited

ABN

99 009 179 551

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may be
issued
Fully paid ordinary shares (IMU) (“Shares”)
and quoted Options (IMUOA) (“Options”).
112,846,288 Shares and 56,423,257
Options issued pursuant to Rights issue and
underwriting arrangements.
186,111,117 Options issued as attaching
Options to Shares issued pursuant to private
placement on 6 December 2017.
  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 1

Appendix 3B New issue announcement

3 Principal terms of the[+] securities Fully paid ordinary shares (eg, if options, exercise price and expiry +securities, date; if the partly amount paid Options with an exercise price of $0.026 per option each option exercisable for one outstanding and due dates for + Share in the Company at any time up to and payment; if convertible including 30 November 2020. securities, the conversion price and dates for conversion)

  • See chapter 19 for defined terms.

Appendix 3B Page 2

01/08/2012

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in The Shares will be quoted and rank equally all respects from the date of with all other quoted Shares on issue in the allotment with an existing[+] class Company. of quoted[+] securities? The Options will be quoted and are a new If the additional securities do not class of securities and may only be rank equally, please state: exercised in accordance with their terms  the date from which they do and conditions. Upon exercise of the  the extent to which they options to fully paid ordinary shares, the participate for the next shares will rank equally with existing dividend, (in the case of a quoted fully paid ordinary shares on issue. trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Shares: $0.018 per Share. Options: Nil 6 Purpose of the issue 112,846,288 Shares and 56,423,257 Options (If issued as consideration for the issued pursuant to Rights issue and acquisition of assets, clearly underwriting arrangements. identify those assets) 186,111,117 Options issued as attaching Options to Shares issued pursuant to private placement on 6 December 2017.

6a Is the entity an[+] eligible entity Yes that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder 14 November 2017 resolution under rule 7.1A was passed

  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 3

Appendix 3B New issue announcement

6c
Number
of
+securities
issued
without security holder approval
under rule 7.1
6d
Number of+securities issued with
security holder approval under
rule 7.1A
6e
Number of+securities issued with
security holder approval under
rule 7.3, or another specific
security holder approval (specify
date of meeting)
6f
Number of securities issued under
an exception in rule 7.2
6g
If securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
issue
date and both values.
Include the source of the VWAP
calculation.
6h
If securities were issued under
rule
7.1A
for
non-cash
consideration, state date on which
valuation of consideration was
released
to
ASX
Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
Dates of entering+securities into
uncertificated
holdings
or
despatch of certificates
186,111,117 Options
Nil
Nil
112,846,288 Shares and 56,423,257 Options

N/A
N/A
N/A
22 December 2017
  • See chapter 19 for defined terms.

Appendix 3B Page 4

01/08/2012

Appendix 3B New issue announcement

8
Number
and
+class
of
all
+securities
quoted
on
ASX
(including the securities in section
2 if applicable)
Number +Class
2,854,807,170
242,534,374
Fully paid ordinary
shares (IMU)
Options exercisable
at $0.026 expiring
on 30 November
2020 (IMUOA)
  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 5

Appendix 3B New issue announcement

9
Number
and
+class
of
all
+securities not quoted on ASX
(including the securities in section
2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number
+Class
2,500,000
10,000,000
2,500,000
2,500,000
9,000,000
9,000,000
9,000,000
5,000,000
5,000,000
10,000,000
Options exercisable
at $0.025 expiring
14/07/2019
Options exercisable
at $0.015 expiring
26/10/2018
Options exercisable
at $0.0125 expiring
26/10/2019
Options exercisable
at $0.0175 expiring
26/10/2019
Options exercisable
at $0.0125 expiring
14/09/2020
Options exercisable
at $0.015 expiring
14/09/2020
Options exercisable
at $0.0175 expiring
14/09/2020
Options exercisable
at $0.02 expiring
30/06/2020
Options exercisable
at $0.025 expiring
30/06/2020
Options exercisable
at $0.02 expiring
4/12/2020
Unchanged
  • See chapter 19 for defined terms.

Appendix 3B Page 6

01/08/2012

Appendix 3B New issue announcement

Part 2 - Bonus issue or pro rata issue

11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will
be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has+security holders who
will
not
be
sent
new
issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
No
Non-renounceable
1 for 21 with 1 attaching Option for every
2 New Shares issued
Fully paid ordinary shares
29 November 2017
N/A
Fractional entitlements rounded up
All countries other than Australia and New
Zealand
18 December 2017
  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 7

Appendix 3B New issue announcement

20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount
of
any
handling
fee
payable to brokers who lodge
acceptances or renunciations on
behalf of+security holders
25
If the issue is contingent on
+security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent
to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do+security holders sell their
entitlements in full through a
broker?
31
How do+security holders sell part
of their entitlements through a
broker and accept for the balance?
Bell Potter Securities Limited
7% of the gross proceeds of the
Entitlement Offer(excludingGST)
N/A
N/A
N/A
N/A
4 December 2017
24 November 2017
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 8

01/08/2012

Appendix 3B New issue announcement

  • 32 How do[+] security holders dispose N/A of their entitlements (except by sale through a broker)?

  • 33 +Issue date

22 December 2017

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities (tick one)

  • (a) Securities described in Part 1 (Shares and Options)

  • (b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional[+] securities (N/A)

  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 9

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted[+] securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) Number +Class 42 Number and[+] class of all[+] securities quoted on ASX (including the securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 10

01/08/2012

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Date: 22/12/17 (Company secretary)

Print name: Justyn Stedwell

  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 11

Appendix 3B New issue announcement

== == == == ==

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

  • Insert number of fully paid ordinary 2,165,179,518 securities on issue 12 months before date of issue or agreement to issue Add the following: 317,405,429

  • • Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

  • Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

  • Number of partly paid ordinary securities that became fully paid in that 12 month period

  • Note:

  • Include only ordinary securities here – other classes of equity securities cannot be added

  • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

Subtract the number of fully paid ordinary Nil securities cancelled during that 12 month period “A” 2,482,584,947

  • See chapter 19 for defined terms.

Appendix 3B Page 12

01/08/2012

Appendix 3B New issue announcement

==> picture [390 x 620] intentionally omitted <==

----- Start of picture text -----

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 372,387,742
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of equity securities issued or
agreed to be issued in that 12 month period
not counting those issued: 135,248,358 Shares
186,111,117 Options
• Under an exception in rule 7.2 Total: 321,359,475
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C” 321,359,475
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 372,387,742
Note: number must be same as shown in
Step 2
Subtract “C” 321,359,475
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C” 51,028,267
[Note: this is the remaining placement
capacity under rule 7.1]
----- End of picture text -----

  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 13

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 2,482,584,947 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 248,258,495 Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used Insert number of equity securities issued or agreed to be issued in that 12 month period 236,973,865 under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items 236,973,865 “E”

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

  • See chapter 19 for defined terms.

Appendix 3B Page 14

01/08/2012

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10
Note: number must be same as shown in
Step 2
248,258,495
Subtract“E”
Note: number must be same as shown in
Step 3
236,973,865
Total[“A” x 0.10] – “E” 11,284,630
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

01/08/2012

Appendix 3B Page 15